Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

524 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Concomitant hyperthermia and radiation therapy for treating locally advanced rectal cancer.
De Haas-Kock DF, Buijsen J, Pijls-Johannesma M, Lutgens L, Lammering G, van Mastrigt GA, De Ruysscher DK, Lambin P, van der Zee J. De Haas-Kock DF, et al. Among authors: van der zee j, van mastrigt ga. Cochrane Database Syst Rev. 2009 Jul 8;(3):CD006269. doi: 10.1002/14651858.CD006269.pub2. Cochrane Database Syst Rev. 2009. PMID: 19588384 Review.
Radiotherapy and hyperthermia for treatment of primary locally advanced cervix cancer: results in 378 patients.
Franckena M, Lutgens LC, Koper PC, Kleynen CE, van der Steen-Banasik EM, Jobsen JJ, Leer JW, Creutzberg CL, Dielwart MF, van Norden Y, Canters RA, van Rhoon GC, van der Zee J. Franckena M, et al. Among authors: van norden y, van der zee j, van rhoon gc, van der steen banasik em. Int J Radiat Oncol Biol Phys. 2009 Jan 1;73(1):242-50. doi: 10.1016/j.ijrobp.2008.03.072. Epub 2008 Nov 5. Int J Radiat Oncol Biol Phys. 2009. PMID: 18990505 Clinical Trial.
Radiation therapy combined with hyperthermia versus cisplatin for locally advanced cervical cancer: Results of the randomized RADCHOC trial.
Lutgens LC, Koper PC, Jobsen JJ, van der Steen-Banasik EM, Creutzberg CL, van den Berg HA, Ottevanger PB, van Rhoon GC, van Doorn HC, Houben R, van der Zee J. Lutgens LC, et al. Among authors: van der zee j, van doorn hc, van rhoon gc, van den berg ha, van der steen banasik em. Radiother Oncol. 2016 Sep;120(3):378-382. doi: 10.1016/j.radonc.2016.02.010. Epub 2016 Feb 17. Radiother Oncol. 2016. PMID: 26897513 Clinical Trial.
Point-counterpoint: what is the optimal trial design to test hyperthermia for carcinoma of the cervix? Point: addition of hyperthermia or cisplatin to radiotherapy for patients with cervical cancer; two promising combinations--no definite conclusions.
van der Zee J, Koper PC, Lutgens LC, Burger CW. van der Zee J, et al. Int J Hyperthermia. 2002 Jan-Feb;18(1):19-24. doi: 10.1080/02656730110083738. Int J Hyperthermia. 2002. PMID: 11824390 Free article. Review.
Cervical cancer: radiotherapy and hyperthermia.
van der Zee J, van Rhoon GC. van der Zee J, et al. Among authors: van rhoon gc. Int J Hyperthermia. 2006 May;22(3):229-34. doi: 10.1080/02656730600722578. Int J Hyperthermia. 2006. PMID: 16754343 Free article. Review.
A phase I/II study of combined weekly systemic cisplatin and locoregional hyperthermia in patients with previously irradiated recurrent carcinoma of the uterine cervix.
de Wit R, van der Zee J, van der Burg ME, Kruit WH, Logmans A, van Rhoon GC, Verweij J. de Wit R, et al. Among authors: van der zee j, van rhoon gc, van der burg me. Br J Cancer. 1999 Jul;80(9):1387-91. doi: 10.1038/sj.bjc.6690533. Br J Cancer. 1999. PMID: 10424740 Free PMC article. Clinical Trial.
Long-term improvement in treatment outcome after radiotherapy and hyperthermia in locoregionally advanced cervix cancer: an update of the Dutch Deep Hyperthermia Trial.
Franckena M, Stalpers LJ, Koper PC, Wiggenraad RG, Hoogenraad WJ, van Dijk JD, Wárlám-Rodenhuis CC, Jobsen JJ, van Rhoon GC, van der Zee J. Franckena M, et al. Among authors: van dijk jd, van der zee j, van rhoon gc. Int J Radiat Oncol Biol Phys. 2008 Mar 15;70(4):1176-82. doi: 10.1016/j.ijrobp.2007.07.2348. Epub 2007 Sep 19. Int J Radiat Oncol Biol Phys. 2008. PMID: 17881144 Clinical Trial.
524 results